Regulating mammalian checkpoints through Cdc25 inactivation

EMBO Reports

Volumn 4, Issue 7, 2003, Pages 671-677

  Donzelli, Maddalena ^a   Draetta, Giulio F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; PROTEIN TYROSINE PHOSPHATASE; ATM PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN B; CYCLIN DEPENDENT KINASE 1;

ACCURACY; BIOCHEMISTRY; CARCINOGENESIS; CELL CYCLE; CENTROSOME; CHROMOSOME ABERRATION; CHROMOSOME SEGREGATION; DNA DAMAGE; DNA REPLICATION; ENZYME INACTIVATION; EUKARYOTE; GENETIC STABILITY; HUMAN; MAMMAL; MONITORING; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SPINDLE CELL; BIOCHEMICAL ANALYSIS; CANCER CELL LINE; CELL CYCLE ASSAY; CELL CYCLE CHECKPOINT; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; DNA DAMAGE CHECKPOINT; ENZYME MECHANISM; G2 PHASE CELL CYCLE CHECKPOINT; MAMMAL CELL; NEOPLASM; PROTEIN DEPHOSPHORYLATION;

ANIMALS; CDC25 PHOSPHATASE; CELL CYCLE; DNA DAMAGE; NEOPLASMS;

EUKARYOTA; MAMMALIA;

EID: 0043066731     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.embor887     Document Type: Review

References (68)

1. Baldin, V., Cans, C., Knibiehler, M. & Ducommun, B. (1997) Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J. Biol. Chem., 272, 32731-32734.
2. Bartek, J. & Lukas, J. (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol., 13, 738-747.
3. Bell, D.W. et al. (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, 286, 2528-2531.
4. Bernardi, R., Liebermann, D.A. & Hoffman, B. (2000) Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene, 19, 2447-2454.
5. Blomberg, I. & Hoffmann, I. (1999) Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol. Cell. Biol., 19, 6183-6194.
6. Bulavin, D.V., Higashimoto, Y., Popoff, I.J., Gaarde, W.A., Basrur, V., Potapova, O., Appella, E. & Fornace, A.J. Jr. (2001) Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature, 411, 102-107.
7. Chen, L., Liu, T.H. & Walworth, N.C. (1999) Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage. Genes Dev., 13, 675-685.
8. Chen, M.S., Hurov, J., White, L.S., Woodford-Thomas, T. & Piwnica-Worms, H. (2001) Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol. Cell. Biol., 21, 3853-3861.
9. Chen, F., Zhang, Z., Bower, J., Lu, Y., Leonard, S.S., Ding, M., Castranova, V., Piwnica-Worms, H. & Shi, X. (2002) Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA, 99, 1990-1995.
10. Dalal, S.N., Schweitzer, C.M., Gan, J. & DeCaprio, J.A. (1999) Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol. Cell. Biol., 19, 4465-4479.
11. Donzelli, M., Squatrito, M., Ganoth, D., Hershko, A., Pagano, M. & Draetta, G.F. (2002) Dual mode of degradation of Cdc25 A phosphatase. EMBO J., 21, 4875-4884.
12. Dunphy, W.G. & Kumagai, A. (1991) The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67, 189-196.
13. Falck, J., Mailand, N., Syljuasen, R.G., Bartek, J. & Lukas, J. (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 410, 842-847.
14. Falck, J., Petrini, J.H., Williams, B.R., Lukas, J. & Bartek, J. (2002) The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Genet., 30, 290-294.
15. Furnari, B., Rhind, N. & Russell, P. (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science, 277, 1495-1497.
16. Gabrielli, B.G., De Souza, C.P., Tonks, I.D., Clark, J.M., Hayward, N.K. & Ellem, K.A. (1996) Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci., 109, 1081-1093.
17. Gabrielli, B.G., Clark, J.M., McCormack, A.K. & Ellem, K.A. (1997) Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2. J. Biol. Chem., 272, 28607-28614.
18. Galaktionov, K. & Beach, D. (1991) Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell, 67, 1181-1194.
19. Galaktionov, K., Lee, A.K., Eckstein, J., Draetta, G., Meckler, J., Loda, M. & Beach, D. (1995) CDC25 phosphatases as potential human oncogenes. Science, 269, 1575-1577.
20. Galaktionov, K., Chen, X. & Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
21. Glover, D.M., Hagan, I.M. & Tavares, A.A. (1998) Polo-like kinases: a team that plays throughout mitosis. Genes Dev., 12, 3777-3787.
22. Graves, P.R., Lovly, C.M., Uy, G.L. & Piwnica-Worms, H. (2001) Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene, 20, 1839-1851.
23. Heald, R., McLoughlin, M. & McKeon, F. (1993) Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell, 74, 463-474.
24. Hirao, A. et al. (2002) Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol., 22, 6521-6532.
25. Hoffmann, I., Clarke, P.R., Marcote, M.J., Karsenti, E. & Draetta, G. (1993) Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J., 12, 53-63.
26. Hoffmann, I., Draetta, G. & Karsenti, E. (1994) Activation of the phosphatase activity of human cdc25A by a Cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J., 13, 4302-4310.
27. Jessus, C. & Beach, D. (1992) Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B. Cell, 68, 323-332.
28. Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H. & Okayama, H. (1994) Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13, 1549-1556.
29. Karlsson, C., Katich, S., Hagting, A., Hoffmann, I. & Pines, J. (1999) Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J. Cell Biol., 146, 573-584.
30. Kumagai, A. & Dunphy, W.G. (1999) Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev., 13, 1067-1072.
31. Kumagai, A., Guo, Z., Emami, K.H., Wang, S.X. & Dunphy, W.G. (1998a) The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J. Cell Biol., 142, 1559-1569.
32. Kumagai, A., Yakowec, P.S. & Dunphy, W.G. (1998b) 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol. Biol. Cell, 9, 345-354.
33. Lammer, C., Wagerer, S., Saffrich, R., Mertens, D., Ansorge, W. & Hoffmann, I. (1998) The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J. Cell Sci., 111, 2445-2453.
34. Liu, Q. et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev., 14, 1448-1459.
35. Lopez-Girona, A., Furnari, B., Mondesert, O. & Russell, P. (1999) Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature, 397, 172-175.
36. Lopez-Girona, A., Kanoh, J. & Russell, P. (2001) Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast. Curr. Biol., 11, 50-54.
37. Mailand, N., Falck, J., Lukas, C., Syljuasen, R.G., Welcker, M., Bartek, J. & Lukas, J. (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science, 288, 1425-1429.
38. Mailand, N., Podtelejnikov, A.V., Groth, A., Mann, M., Bartek, J. & Lukas, J. (2002) Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J., 21, 5911-5920.
39. Matsuoka, S., Huang, M. & Elledge, S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282, 1893-1897.
40. Millar, J.B., Blevitt, J., Gerace, L., Sadhu, K., Featherstone, C. & Russell, P. (1991 ) p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proc. Natl Acad. Sci. USA, 88, 10500-10504.
41. Molinari, M., Mercurio, C., Dominguez, J., Goubin, F. & Draetta, G.F. (2000) Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep., 1, 71-79.
42. Muslin, A.J., Tanner, J.W., Allen, P.M. & Shaw, A.S. (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell, 84, 889-897.
43. Nigg, E.A. (1998) Polo-like kinases: positive regulators of cell division from start to finish. Curr. Opin. Cell Biol., 10, 776-783.
44. Nishijima, H., Nishitani, H., Seki, T. & Nishimoto, T. (1997) A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea. J. Cell Biol., 138, 1105-1116.
45. Nurse, P. (1997) Checkpoint pathways come of age. Cell, 91, 865-867.
46. Painter, R.B. & Young, B.R. (1980) Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl Acad. Sci. USA, 77, 7315-7317.
47. Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S. & Piwnica-Worms, H. (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505.
48. Peng, C.Y., Graves, P.R., Ogg, S., Thoma, R.S., Byrnes, M.J., Wu, Z., Stephenson, M.T. & Piwnica-Worms, H. (1998) C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ., 9, 197-208.
49. Peters, J.M. (2002) The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell, 9, 931-943.
50. Pines, J. (1999) Four-dimensional control of the cell cycle. Nature Cell Biol., 1, E73-E79.
51. Raleigh, J.M. & O'Connell, M.J. (2000) The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J. Cell Sci., 113, 1727-1736.
52. Russell, P. & Nurse, P. (1986) cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell, 45, 145-153.
53. Sanchez, Y., Wong, C., Thoma, R.S., Richman, R., Wu, Z., Piwnica-Worms, H. & Elledge, S.J. (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 277, 1497-1501.
54. Sexl, V, Diehl, J.A., Sherr, C.J., Ashmun, R., Beach, D. & Roussel, M.F. (1999) A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene, 18, 573-582.
55. Shiloh, Y. (2001 ) ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev., 11, 71-77.
56. Shiloh, Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nature Rev. Cancer, 3, 155-168.
57. Sørensen, C., Syljuåsen, R.G., Falck J., Schroeder, T., Rönnstrand, L., Khanna, K.K., Zhou, B.-B., Bartek, J. & Lukas, J. (2003) Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell, 3, 247-258.
58. Strohmaier, H., Spruck, C.H., Kaiser, P., Won, K.A., Sangfelt, O. & Reed, S.I. (2001) Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature, 413, 316-322.
59. Takemasa, I. et al. (2000) Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res., 60, 3043-3050.
60. Takizawa, C.G. & Morgan, D.O. (2000) Control of mitosis by changes in the subcellular location of cyclin-B1 - Cdk1 and Cdc25C. Curr. Opin. Cell Biol., 12, 658-665.
61. Toyoshima-Morimoto, F., Taniguchi, E. & Nishida, E. (2002) Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep., 3, 341-348.
62. Vigo, E., Muller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M.C. & Helin, K. (1999) CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol., 19, 6379-6395.
63. Yaffe, M.B., Rittinger, K., Volinia, S., Caron, P.R., Aitken, A., Leffers, H., Gamblin, S.J., Smerdon, S.J. & Cantley, L.C. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell, 91, 961-971.
64. Yang, J., Winkler, K., Yoshida, M. & Kornbluth, S. (1999) Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J., 18, 2174-2183.
65. Yao, Y., Slosberg, E.D., Wang, L., Hibshoosh, H., Zhang, Y.J., Xing, W.Q., Santella, R.M. & Weinstein, I.B. (1999) Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice. Oncogene, 18, 5159-5166.
66. Zeng, Y. & Piwnica-Worms, H. (1999) DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol. Cell. Biol., 19, 7410-7419.
67. Zhao, H., Watkins, J.L. & Piwnica-Worms, H. (2002) Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl Acad. Sci. USA, 99, 14795-14800.
68. Zhou, B.B. & Elledge, S.J. (2000) The DNA damage response: putting checkpoints in perspective. Nature, 408, 433-439.